FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109474071> ?p ?o ?g. }

• W2109474071 endingPage "8" @default.
• W2109474071 startingPage "8890" @default.
• W2109474071 abstract "The multifaceted nature of the angiogenic process in malignant neoplasms suggests that protocols that combine antiangiogenic agents may be more effective than single-agent therapies. However it is unclear which combination of agents would be most efficacious and will have the highest degree of synergistic activity while maintaining low overall toxicity. Here we investigate the concept of combining a direct angiogenesis inhibitor (endostatin) with an indirect antiangiogenic compound [SU5416, a vascular endothelial growth factor receptor 2 (VEGFR2) receptor tyrosine kinase (RTK) inhibitor]. These angiogenic agents were more effective in combination than when used alone in vitro (endothelial cell proliferation, survival, migration/invasion, and tube formation tests) and in vivo. The combination of SU5416 and low-dose endostatin further reduced tumor growth versus monotherapy in human prostate (PC3), lung (A459), and glioma (U87) xenograft models, and reduced functional microvessel density, tumor microcirculation, and blood perfusion as detected by intravital microscopy and contrast-enhanced Doppler ultrasound. One plausible explanation for the efficacious combination could be that, whereas SU5416 specifically inhibits vascular endothelial growth factor signaling, low-dose endostatin is able to inhibit a broader spectrum of diverse angiogenic pathways directly in the endothelium. The direct antiangiogenic agent might be able to suppress alternative angiogenic pathways up-regulated by the tumor in response to the indirect, specific pathway inhibition. For future clinical evaluation of the concept, a variety of agents with similar mechanistic properties could be tested." @default.
• W2109474071 created "2016-06-24" @default.
• W2109474071 creator A5004062115 @default.
• W2109474071 creator A5014378554 @default.
• W2109474071 creator A5024625271 @default.
• W2109474071 creator A5029557006 @default.
• W2109474071 creator A5034908463 @default.
• W2109474071 creator A5049156295 @default.
• W2109474071 creator A5052369065 @default.
• W2109474071 creator A5062576992 @default.
• W2109474071 creator A5073316865 @default.
• W2109474071 creator A5075116222 @default.
• W2109474071 creator A5075119102 @default.
• W2109474071 creator A5078003238 @default.
• W2109474071 creator A5082159954 @default.
• W2109474071 creator A5086658735 @default.
• W2109474071 creator A5086968245 @default.
• W2109474071 date "2003-12-15" @default.
• W2109474071 modified "2023-09-25" @default.
• W2109474071 title "Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects." @default.
• W2109474071 cites W143705936 @default.
• W2109474071 cites W1480076252 @default.
• W2109474071 cites W1482076735 @default.
• W2109474071 cites W1504679135 @default.
• W2109474071 cites W1564365085 @default.
• W2109474071 cites W1573363574 @default.
• W2109474071 cites W1603230122 @default.
• W2109474071 cites W1641237256 @default.
• W2109474071 cites W1658047882 @default.
• W2109474071 cites W1896634820 @default.
• W2109474071 cites W1915767302 @default.
• W2109474071 cites W1943173994 @default.
• W2109474071 cites W1953884850 @default.
• W2109474071 cites W1970613781 @default.
• W2109474071 cites W1978139448 @default.
• W2109474071 cites W1992073551 @default.
• W2109474071 cites W1992134233 @default.
• W2109474071 cites W2015809080 @default.
• W2109474071 cites W2027894802 @default.
• W2109474071 cites W2029883816 @default.
• W2109474071 cites W2042288131 @default.
• W2109474071 cites W2042604169 @default.
• W2109474071 cites W2050777370 @default.
• W2109474071 cites W2053430576 @default.
• W2109474071 cites W2064360454 @default.
• W2109474071 cites W2088680427 @default.
• W2109474071 cites W2097603205 @default.
• W2109474071 cites W2097659220 @default.
• W2109474071 cites W2101217334 @default.
• W2109474071 cites W2113101033 @default.
• W2109474071 cites W2122210701 @default.
• W2109474071 cites W2124974853 @default.
• W2109474071 cites W2125048739 @default.
• W2109474071 cites W2131798870 @default.
• W2109474071 cites W2141954642 @default.
• W2109474071 cites W2144531125 @default.
• W2109474071 cites W2144939915 @default.
• W2109474071 cites W2151619744 @default.
• W2109474071 cites W2157642143 @default.
• W2109474071 cites W2166094737 @default.
• W2109474071 cites W2166825418 @default.
• W2109474071 cites W2167455663 @default.
• W2109474071 cites W2318535961 @default.
• W2109474071 cites W2336388990 @default.
• W2109474071 cites W2340438890 @default.
• W2109474071 cites W2415462387 @default.
• W2109474071 cites W2419487429 @default.
• W2109474071 cites W1592193248 @default.
• W2109474071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14695206" @default.
• W2109474071 hasPublicationYear "2003" @default.
• W2109474071 type Work @default.
• W2109474071 sameAs 2109474071 @default.
• W2109474071 citedByCount "55" @default.
• W2109474071 countsByYear W21094740712012 @default.
• W2109474071 countsByYear W21094740712013 @default.
• W2109474071 countsByYear W21094740712014 @default.
• W2109474071 countsByYear W21094740712015 @default.
• W2109474071 countsByYear W21094740712016 @default.
• W2109474071 countsByYear W21094740712018 @default.
• W2109474071 countsByYear W21094740712019 @default.
• W2109474071 countsByYear W21094740712021 @default.
• W2109474071 countsByYear W21094740712022 @default.
• W2109474071 countsByYear W21094740712023 @default.
• W2109474071 crossrefType "journal-article" @default.
• W2109474071 hasAuthorship W2109474071A5004062115 @default.
• W2109474071 hasAuthorship W2109474071A5014378554 @default.
• W2109474071 hasAuthorship W2109474071A5024625271 @default.
• W2109474071 hasAuthorship W2109474071A5029557006 @default.
• W2109474071 hasAuthorship W2109474071A5034908463 @default.
• W2109474071 hasAuthorship W2109474071A5049156295 @default.
• W2109474071 hasAuthorship W2109474071A5052369065 @default.
• W2109474071 hasAuthorship W2109474071A5062576992 @default.
• W2109474071 hasAuthorship W2109474071A5073316865 @default.
• W2109474071 hasAuthorship W2109474071A5075116222 @default.
• W2109474071 hasAuthorship W2109474071A5075119102 @default.
• W2109474071 hasAuthorship W2109474071A5078003238 @default.
• W2109474071 hasAuthorship W2109474071A5082159954 @default.
• W2109474071 hasAuthorship W2109474071A5086658735 @default.

• next